NCT01671449View on ClinicalTrials.gov

S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

338

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2015

Conditions
Gastric Cancer
Interventions
DRUG

S-1

S-1 : 40 mg/m2, twice daily, Day 1-14

DRUG

Cisplatin

60 mg/m2/day Day 1

DRUG

Oxaliplatin

130 mg/m2/day Day 1

Trial Locations (9)

463-707

Seoul National University Bundang Hospital, Bundang-gu, Seongnam-si

Unknown

National Cancer Center, Ilsan

519-763

Chonnam National University Hwasun Hospital, Hwasun-eup, Hwasun-gun

361-711

Chungbuk National University Hospital, Cheongju-si

619-953

Dongnam Institute of Radiological and Medical Sciences, Busan

705-717

Yeungnam University Medical Center, Daegu

210-711

Gangneung Asan Hospital, Gangneung-si

137-701

Seoul St. Mary's hospital of the Catholic University of Korea, Seoul

138-736

Asan Medical Center, Seoul

All Listed Sponsors
lead

Min-Hee Ryu

OTHER

NCT01671449 - S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter